메뉴 건너뛰기




Volumn 20, Issue 8, 2013, Pages 524-529

Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirin

(22)  Manns, M P a   Pockros, P J b   Norkrans, G c   Smith, C I d   Morgan, T R e   Haussinger D f   Shiffman, M L g   Hadziyannis, S J h   Schmidt, W N i   Jacobson, I M j   Barcena R k   Schiff, E R l   Shaikh, O S m   Bacon, B n   Marcellin, P o   Deng, W p   Esteban Mur, R q   Poynard, T r   Pedicone, L D p   Brass, C A p   more..


Author keywords

clinical; cure; eradication; follow up; longitudinal

Indexed keywords

ALPHA2B INTERFERON; PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS RNA;

EID: 84879795584     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12074     Document Type: Article
Times cited : (76)

References (11)
  • 1
    • 15644380122 scopus 로고    scopus 로고
    • Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy
    • Marcellin P, Boyer N, Gervais A, et al,. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann Intern Med 1997; 127: 875-881.
    • (1997) Ann Intern Med , vol.127 , pp. 875-881
    • Marcellin, P.1    Boyer, N.2    Gervais, A.3
  • 2
    • 0033058754 scopus 로고    scopus 로고
    • Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon
    • Reichard O, Glaumann H, Fryden A, Norkrans G, Wejstal R, Weiland O,. Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon. J Hepatol 1999; 30: 783-787.
    • (1999) J Hepatol , vol.30 , pp. 783-787
    • Reichard, O.1    Glaumann, H.2    Fryden, A.3    Norkrans, G.4    Wejstal, R.5    Weiland, O.6
  • 4
    • 0035934568 scopus 로고    scopus 로고
    • Peginterferon α-2b plus ribavirin compared with interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
    • Manns MP, McHutchison JG, Gordon SC, et al,. Peginterferon α-2b plus ribavirin compared with interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358: 958-965.
    • (2001) Lancet , vol.358 , pp. 958-965
    • Manns, M.P.1    McHutchison, J.G.2    Gordon, S.C.3
  • 5
    • 0032547944 scopus 로고    scopus 로고
    • Interferon α-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
    • Davis GL, Esteban-Mur R, Rustgi V, et al,. Interferon α-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med 1998; 339: 1493-1499.
    • (1998) N Engl J Med , vol.339 , pp. 1493-1499
    • Davis, G.L.1    Esteban-Mur, R.2    Rustgi, V.3
  • 6
    • 0032547938 scopus 로고    scopus 로고
    • Interferon α-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
    • McHutchison JG, Gordon SC, Schiff ER, et al,. Interferon α-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998; 339: 1485-1492.
    • (1998) N Engl J Med , vol.339 , pp. 1485-1492
    • McHutchison, J.G.1    Gordon, S.C.2    Schiff, E.R.3
  • 7
    • 0032585237 scopus 로고    scopus 로고
    • Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
    • Poynard T, Marcellin P, Lee SS, et al,. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998; 352: 1426-1432.
    • (1998) Lancet , vol.352 , pp. 1426-1432
    • Poynard, T.1    Marcellin, P.2    Lee, S.S.3
  • 8
    • 17844403232 scopus 로고    scopus 로고
    • A randomized, double-blind trial comparing pegylated interferon α-2b to interferon α-2b as initial treatment for chronic hepatitis C
    • Lindsay KL, Trepo C, Heintges T, et al,. A randomized, double-blind trial comparing pegylated interferon α-2b to interferon α-2b as initial treatment for chronic hepatitis C. Hepatology 2001; 34: 395-403.
    • (2001) Hepatology , vol.34 , pp. 395-403
    • Lindsay, K.L.1    Trepo, C.2    Heintges, T.3
  • 9
    • 33645968702 scopus 로고    scopus 로고
    • Sustained virological response rates and durability of the response to interferon-based therapies in hepatitis C patients treated in the clinical setting
    • Desmond CP, Roberts SK, Dudley F, et al,. Sustained virological response rates and durability of the response to interferon-based therapies in hepatitis C patients treated in the clinical setting. J Viral Hepat 2006; 13: 311-315.
    • (2006) J Viral Hepat , vol.13 , pp. 311-315
    • Desmond, C.P.1    Roberts, S.K.2    Dudley, F.3
  • 10
    • 74049109303 scopus 로고    scopus 로고
    • Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients
    • Giannini EG, Basso M, Savarino V, Picciotto A,. Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients. Aliment Pharmacol Ther 2010; 31: 502-508.
    • (2010) Aliment Pharmacol Ther , vol.31 , pp. 502-508
    • Giannini, E.G.1    Basso, M.2    Savarino, V.3    Picciotto, A.4
  • 11
    • 78049476361 scopus 로고    scopus 로고
    • A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon α-2a and ribavirin
    • Swain MG, Lai MY, Shiffman ML, et al,. A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon α-2a and ribavirin. Gastroenterology 2010; 139: 1593-1601.
    • (2010) Gastroenterology , vol.139 , pp. 1593-1601
    • Swain, M.G.1    Lai, M.Y.2    Shiffman, M.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.